Evaluation of the hepatoprotective effects and pharmacokinetics of pedunculoside in vitro and in vivo
European Journal of Pharmacology · 2025
DOI: 10.1016/j.ejphar.2025.178359 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Pharmacology, 2025. Verfasst von Xinxin Chen und 10 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacy, Guangxi University of Chinese Medicine, Nanning, 530000, Hong Kong Special Administrative Region of China; The Second School of …. Hauptthemen laut MEDLINE: Triterpenes, Protective Agents, Chemical and Drug Induced Liver Injury. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Guangxi University of Chinese Medicine, National Natural Science Foundation of China, Specific Research Project of Guangxi for Research Bases and Talents.
Abstract (Originalsprache)
Pedunculoside (PE), a triterpenoid saponin isolated from Ilex rotunda Thunb., exhibits an anti-inflammatory effect; however, its hepatoprotective effects and pharmacokinetics are still unclear. Thus, an integrated strategy using network pharmacology and pharmacokinetics was used to investigate the hepatoprotective effects of PE. A simple, sensitive, and reliable LC-MS/MS method was established for the quantitative analysis of PE to elucidate its pharmacokinetics in normal rats and those with acute liver injury (ALI). LO2 cells and carbon tetrachloride-treated rats were used to evaluate the hepatoprotective effects and mechanism of PE in vitro and in vivo, respectively. The blood concentration curve demonstrated a decrease in clearance (CL) and an increase in the area under the curve (AUC(0-∞)) and mean residence time (MRT) in rats with ALI. Normal rats in the intravenous injection group had a CL of 36.80 L/h/kg, AUC(0-∞) of 1092.01 μg/L•h, and MRT(0-∞) of 0.93 h. In contrast, the CL of rats with ALI was 34.54 L/h/kg, AUC(0-∞) was 1170.01 μg/L•h, and MRT was 1.16 h. Similar results were obtained for rats in the intraperitoneal injection group. Qualitative studies of rat metabolites identified 19 metabolites, indicating that PE mainly undergoes phase I metabolism followed by phase II metabolism to a lesser extent. As rats with ALI showed a liver-targeting trend, network pharmacology was used to predict 20 potential ALI-related targets, among which the nuclear factor-kappa B (NF-κB) pathway had the strongest correlation. PE exhibited a protective effect on ALI by decreasing the levels of alanine transaminase, aspartate transaminase, and the pro-inflammatory cytokines tumor necrosis factor-α, interleukin (IL)-1β, and IL-6, wherein the mechanism was related to the NF-κB pathway. Thus, PE exhibited a significant protective effect against ALI through the NF-κB pathway.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Pharmacy, Guangxi University of Chinese Medicine, Nanning, 530000, Hong Kong Special Administrative Region of China; The Second School of Clinical Medicine, Zhejiang Chinese Medical University, Hangzhou, 3114…
- Department of Rehabilitation Sciences, Faculty of Health and Social Sciences, Hong Kong Polytechnic University, 999077, Hong Kong Special Administrative Region of China; The Research Centre for Chinese Medicine Innovati…
- College of Pharmacy, Guangxi University of Chinese Medicine, Nanning, 530000, Hong Kong Special Administrative Region of China.
- Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, Hong Kong Special Administrative Region of China.
- The Research Centre for Chinese Medicine Innovation, Hong Kong Polytechnic University, Hung Hom, Kowloon, 999077, Hong Kong Special Administrative Region of China; Department of Food Science and Nutrition, Faculty of Sc…
- Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong, 999077, Hong Kong Special Administrative Region of China. Electronic address: gphleung@hku.hk.
Förderung
- Guangxi University of Chinese Medicine
- National Natural Science Foundation of China
- Specific Research Project of Guangxi for Research Bases and Talents
Zitieren
APA
Chen, X., Li, J., Qiu, H., Liu, Z., Wang, Z. T., Yang, S., Seto, S. W., Ming-Yuen Lee, S., Pak-Heng Leung, G., Yuan, R., & Gao, H. (2025). Evaluation of the hepatoprotective effects and pharmacokinetics of pedunculoside in vitro and in vivo. European Journal of Pharmacology. https://doi.org/10.1016/j.ejphar.2025.178359
Vancouver
Chen X, Li J, Qiu H, Liu Z, Wang ZT, Yang S, et al. Evaluation of the hepatoprotective effects and pharmacokinetics of pedunculoside in vitro and in vivo. European Journal of Pharmacology. 2025. doi:10.1016/j.ejphar.2025.178359
BibTeX
@article{Chen2025,
author = {Chen, Xinxin and Li, Jingjing and Qiu, Haixin and Liu, Zhenjie and Wang, Zheng-Tao and Yang, Shilin and Seto, Sai-Wang and Ming-Yuen Lee, Simon and Pak-Heng Leung, George and Yuan, Renyikun and Gao, Hongwei},
title = {Evaluation of the hepatoprotective effects and pharmacokinetics of pedunculoside in vitro and in vivo},
journal = {European Journal of Pharmacology},
year = {2025},
doi = {10.1016/j.ejphar.2025.178359}
}
EUVIMED